Response and radiographic progression in biologic-naive and biologic-experienced patients with rheumatoid arthritis treated with sirukumab

被引:0
|
作者
Thorne, C. [1 ,2 ]
Karpouzas, G. [3 ]
Takeuchi, T. [4 ]
Sheng, S. [5 ]
Xu, W. [5 ]
Xu, S. [5 ]
Kurrasch, R. [6 ]
Fei, K. [5 ]
Hsu, B. [5 ]
机构
[1] Univ Toronto, Toronto, ON M5S 1A1, Canada
[2] Southlake Reg Hlth Ctr, Newmarket, ON, Canada
[3] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[4] Keio Univ, Sch Med, Tokyo 108, Japan
[5] Janssen Res & Dev LLC, Raritan, NJ USA
[6] GlaxoSmithKline, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PP24
引用
收藏
页码:23 / 24
页数:2
相关论文
共 50 条
  • [1] RESPONSE AND RADIOGRAPHIC PROGRESSION IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SIRUKUMAB
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 723 - 723
  • [2] ANALYSIS EFFICACY OF ABATACEPT TREATMENT IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS.
    Borisova, M.
    Lukina, G.
    Yakov, S.
    Luchikhina, E.
    Karateev, D.
    Novikov, A.
    Aleksandrova, E.
    Aronova, E.
    Glukhova, S.
    Nasonov, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1300 - 1300
  • [3] REAL-WORLD EXPERIENCE WITH AN IL-17A BLOCKER IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED RADIOGRAPHIC AND NON-RADIOGRAPHIC AXSPA PATIENTS
    Booth, Nicola
    Hill, Julie
    Leage, Soyi Liu
    Sapin, Christophe
    Holdsworth, Elizabeth
    Antonelli, Silvia
    [J]. RHEUMATOLOGY, 2020, 59 : 128 - 128
  • [4] Clinical and Radiographic Efficacy of Sarilumab Plus Methotrexate in Biologic-Experienced and Biologic-Naive Patients with Rheumatoid Arthritis in a Phase 3, Randomized, Double-blind, Placebo-Controlled Study
    Fiore, Stefano
    Genovese, Mark
    Fan, Chunpeng
    Decktor, Dennis
    Fleischmann, Roy
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1217 - 1217
  • [5] Predictors of Persistency with TNFi in Biologic-Experienced Versus Biologic-Naive Psa Patients Enrolled in the Corrona Registry
    Etzel, C. J.
    Stolshek, Bradley S.
    Rebello, Sabrina
    Collier, David
    Mutebi, Alex
    Wade, Sally W.
    Malley, Wendi
    Greenberg, J. D.
    Harrold, Leslie R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] CLINICAL AND RADIOGRAPHIC EFFICACY OF SARILUMAB PLUS METHOTREXATE IN BIOLOGIC-EXPERIENCED AND BIOLOGIC-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS IN A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL STUDY
    van der Heijde, D.
    Genovese, M. C.
    Fan, C.
    Fiore, S.
    Decktor, D. L.
    Fleischmann, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 722 - 722
  • [7] Characteristics of patients with moderate-to-severe psoriasis treated with secukinumab in US clinical practice-A focus on biologic-naive and biologic-experienced patients
    Feldman, Steven
    Palmer, Jacqueline
    Djatche, Laurence
    Hur, Peter
    Zhao, Yang
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB68 - AB68
  • [8] Health care utilization and cost implications of biologic treatment patterns among biologic-naive and biologic-experienced patients with moderate to severe psoriasis
    Feidman, Steven
    Palmer, Jacqueline
    Wang, Xinyue
    Tian, Haijun
    Wei, Zhongyuan
    Djatche, Laurence
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB151 - AB151
  • [9] Evaluation of abatacept in biologic-naive patients with active rheumatoid arthritis
    Schiff, Michael
    Bessette, Louis
    [J]. CLINICAL RHEUMATOLOGY, 2010, 29 (06) : 583 - 591
  • [10] Real world use of ixekizumab is associated with reductions in concomitant medications among biologic-experienced or biologic-naive patients with psoriasis
    Wu, Jashin J.
    Zhu, Baojin
    Burge, Russel
    Goldblum, Orin
    Choong, Casey
    Edson-Heredia, Emily
    Amato, David
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB114 - AB114